U.S., May 23 -- ClinicalTrials.gov registry received information related to the study (NCT07602933) titled 'Photobiomodulation Effects on Fatigue and Muscle Damage Induced by NMES' on April 27.
Brief Summary: Neuromuscular electrical stimulation (NMES) is widely used to improve muscle strength and mitigate atrophy. However, its clinical efficacy is often limited by early neuromuscular fatigue, muscle damage, and discomfort, which reduce patient tolerance and contraction time. Photobiomodulation (PBM) has emerged as a potential therapy to enhance muscle performance and accelerate recovery by minimizing fatigue and damage. Despite its potential, few studies have investigated the effects of PBM applied specifically before an NMES-evoked fatig...